Website: https://cognoa.com/for-providers/
Canvas Dx is an FDA-authorized diagnostic aid designed to assist healthcare professionals in diagnosing or ruling out Autism Spectrum Disorder (ASD) in children aged 18 to 72 months. Built by Cognoa and powered by Databricks, it combines cutting-edge machine learning with clinical expertise to deliver accurate, timely, and objective diagnostic results.
How It Works:
Healthcare providers invite caregivers to use the Canvas Dx app to answer questionnaires and upload short videos of the child in natural settings. These are analyzed alongside clinician input and reviewed by trained video analysts. Within days, the platform provides one of three outcomes: Positive for ASD, Negative for ASD, or Indeterminate.
Why It’s Useful for Professionals:
Canvas Dx significantly reduces diagnosis time—often by over a year—helping professionals initiate early intervention when it’s most effective. It supports inclusive and equitable assessments by using diverse data and provides DSM-5–mapped reports, making documentation and referrals seamless. For pediatricians, psychologists, and therapists, Canvas Dx simplifies workflows and improves access to timely, accurate autism diagnoses.
